Georgia Medicare Lymphedema Treatment Act Compression Items 2026

If you live in Georgia, are on Medicare, and you developed lymphedema after breast cancer treatment, gynecologic cancer surgery, prostate cancer treatment, melanoma surgery, head and neck cancer therapy, or simply with primary lymphedema you've lived with for years — there is a coverage change you need to know about.

For more than two decades, Medicare paid for outpatient therapy to treat lymphedema (complete decongestive therapy by certified lymphedema therapists at Emory, Wellstar, Piedmont, Cancer Treatment Centers of America Atlanta, Augusta University, Memorial Health Savannah, Phoebe Putney, Northeast Georgia, Atrium Health Navicent, and elsewhere). But Medicare did not pay for the compression garments and bandaging systems beneficiaries had to wear every day, for the rest of their lives, to keep the disease from progressing. Compression garments cost $1,500 to $5,000 or more per year. Most beneficiaries paid out of pocket. Many simply went without — and ended up in the hospital with cellulitis, surgical wounds that wouldn't heal, or progressive disabling lymphedema.

That changed on January 1, 2024.

The Lymphedema Treatment Act — enacted as Section 4133 of Division FF Title IV Subtitle D of the Consolidated Appropriations Act, 2023 (Public Law 117-328, signed December 29, 2022 by President Biden) — added a new Medicare Part B benefit category for standard and custom lymphedema compression treatment items. CMS implemented the benefit through the CY 2024 Home Health Prospective Payment System Final Rule (88 FR 77676, November 13, 2023) and follow-on program instructions. The new HCPCS codes for compression items, the frequency limits, the standard written order requirements, and the DME MAC processing infrastructure all went live January 1, 2024.

For Georgia, the impact is enormous. Each year, thousands of Georgia Medicare beneficiaries develop secondary lymphedema from cancer treatment, particularly breast cancer survivors after axillary lymph node dissection or radiation, gynecologic cancer survivors after pelvic node dissection, prostate cancer survivors after pelvic radiation, and head and neck cancer survivors after cervical node dissection. Add primary lymphedema (often genetic), post-surgical lymphedema from non-cancer surgeries, post-traumatic lymphedema, and filariasis-related lymphedema, and you have a substantial Georgia patient population for whom the Lymphedema Treatment Act is life-changing.

This guide explains the legislative background, the new Part B benefit category, what compression items are covered, the frequency and replacement schedules, documentation requirements, the coordination with outpatient CDT under the post-BBA 2018 therapy framework, how CGS Administrators (the DME MAC for Jurisdiction C, which includes Georgia) processes claims, beneficiary cost-sharing, appeals rights, and how Georgia certified lymphedema therapists, cancer center programs, and DMEPOS suppliers fit into the post-LTA landscape.

This is policy-translator territory. The benefit exists. The codes are in place. The CMS framework is operational. The question for Georgia beneficiaries is whether their care team — oncologist, primary care provider, certified lymphedema therapist, DMEPOS supplier — knows how to access it.

Key takeaways

• The Lymphedema Treatment Act was enacted as Section 4133 of the Consolidated Appropriations Act, 2023 (Public Law 117-328), signed December 29, 2022.
• It added Section 1861(s)(2)(JJ) and Section 1861(iii) to the Social Security Act, creating a new Part B benefit category for lymphedema compression treatment items.
• The benefit took effect January 1, 2024.
• CMS implemented through the CY 2024 HH PPS Final Rule (88 FR 77676, November 13, 2023) and subsequent program instructions.
• Covered items include standard daytime garments, standard nighttime garments, custom-fit garments, compression bandaging systems and supplies for the intensive phase of CDT, gradient compression wraps with adjustable straps (Velcro-closure devices), and accessories (donning/doffing aids, fillers, foam).
• Frequency limits and reasonable and useful lifetime standards govern replacement schedules (e.g., several daytime garments per affected body part per year; nighttime garments at separate frequency; bandaging supplies more frequently during intensive treatment phase).
• A Standard Written Order (SWO) from a physician, NP, PA, or CNS is required.
• Beneficiary cost-sharing: Part B deductible plus 20% coinsurance of the Medicare-allowed amount. Medigap or other supplemental coverage may cover coinsurance.
• CGS Administrators is the DME MAC for Jurisdiction C (which includes Georgia), processing lymphedema compression item claims.
• The LTA benefit works alongside outpatient therapy coverage (Part B PT/OT for CDT, post-BBA 2018 framework) — outpatient therapy delivers the manual treatment; the LTA-covered compression items support daily self-management.
• The LTA closed a two-decade coverage gap advocated by the Lymphedema Advocacy Group and many cancer survivor organizations.
• Major Georgia cancer center programs with lymphedema services include Emory Winship Cancer Institute, Wellstar, Piedmont Cancer Institute, Augusta University Medical Center, Memorial Health Savannah, Phoebe Putney, Northeast Georgia Health System, and Atrium Health Navicent.
• Certified Lymphedema Therapist (CLT) network in Georgia provides the clinical evaluation that supports SWO documentation and ongoing care.
• Standard appeals rights apply to denied claims — redetermination, QIC, ALJ, MAC, federal court.
• Medicare Advantage plans must cover the LTA benefit at least equivalent to Original Medicare; plan-specific procedural requirements vary.

The legislative path

Decades of advocacy

• Founded ~2009-2010, the Lymphedema Advocacy Group organized a multi-year grassroots and legislative campaign
• Bill introduced in successive Congresses
• Supported by cancer survivor organizations (Susan G. Komen, breast cancer advocacy networks, gynecologic cancer organizations, melanoma research foundations)
• Supported by professional organizations (APTA, AOTA, ASHA, NLN — National Lymphedema Network, LE&RN — Lymphatic Education & Research Network)
• Built bipartisan congressional support

Enactment

• Public Law 117-328 — Consolidated Appropriations Act, 2023
• Signed December 29, 2022 by President Biden
• Division FF Title IV Subtitle D Section 4133 is the LTA
• Effective date: January 1, 2024

Statutory text

• Section 1861(s)(2)(JJ) SSA — added lymphedema compression treatment items as a covered Part B service category
• Section 1861(iii) SSA — definitional provision specifying the items covered

CMS implementation

• CY 2024 Home Health Prospective Payment System Final Rule (88 FR 77676), published November 13, 2023
• Despite the "HH PPS" title, the rule includes LTA implementation because that was the available regulatory vehicle for January 1, 2024 effective date
• Established HCPCS codes for compression items
• Set frequency limits and reasonable and useful lifetime standards
• Established SWO requirements
• Established supplier enrollment requirements

What lymphedema is — clinical context

Definition

Lymphedema is the abnormal accumulation of protein-rich fluid in tissues due to impaired lymphatic drainage. It typically affects an extremity (arm, leg) but can affect the trunk, head/neck, breast, or genitals.

Primary lymphedema

• Genetic or developmental abnormality of lymphatic system
• May present at birth, during puberty, or later in life
• Examples: Milroy disease, Meige disease, lymphedema-distichiasis syndrome

Secondary lymphedema

• Result of damage to the lymphatic system
• Most common causes:
  • Cancer treatment: lymph node dissection, radiation
  • Breast cancer: especially axillary node dissection
  • Gynecologic cancers: pelvic node dissection
  • Prostate cancer: pelvic radiation
  • Melanoma: sentinel/regional node procedures
  • Head and neck cancer: cervical node dissection
• Filariasis (parasitic infection — rare in U.S., common in some tropical countries)
• Post-surgical (non-cancer surgeries affecting lymphatic flow)
• Post-traumatic (severe injury)
• Chronic venous insufficiency with secondary lymphedema

Why compression matters

• Compression supports impaired lymphatic return
• Prevents fluid accumulation
• Prevents cellulitis (a common, dangerous complication)
• Prevents skin breakdown
• Maintains function and quality of life
• Required daily, lifelong in most cases

The pre-LTA coverage gap

What was covered (and still is)

• Outpatient therapy under Part B
• Complete Decongestive Therapy (CDT) by qualified therapists (PT/OT with CLT certification)
• Includes manual lymphatic drainage, compression bandaging instruction, exercise, skin care, self-management training
• Subject to post-BBA 2018 KX modifier threshold framework
• Substantive coverage under Section 1862(a)(1)(A) and the Jimmo Settlement

What was NOT covered (pre-January 1, 2024)

• Daytime compression garments
• Nighttime compression garments
• Custom-fit garments
• Compression bandaging systems for home use
• Adjustable Velcro compression wraps
• Donning/doffing aids
• Accessories

The DME definition problem

Section 1861(n) SSA historically defined DME as equipment that:

• "Withstands repeated use"
• Is "primarily and customarily used to serve a medical purpose"
• Generally is "not useful to a person in the absence of an illness or injury"
• Is "appropriate for use in the home"

Compression garments, being soft goods with limited useful lifetime (typically replaced every 6 months for daily use), did not fit the "withstands repeated use" durability concept. They were classified as supplies, not DME — and Medicare generally did not cover supplies under traditional DMEPOS framework absent specific statutory authorization.

The LTA solved this by creating a new benefit category specifically for lymphedema compression treatment items, not requiring them to fit the DME definition.

Covered items under the LTA

CMS implementation specifies covered items in several categories:

Daytime compression garments

• Standard-fit (off-the-shelf) options
• Custom-fit when medical necessity supports
• Multiple per affected body part per year (typically 3-6 daytime garments depending on body part)

Nighttime compression garments

• Generally less daytime durability requirement
• Less frequent replacement than daytime garments
• Examples: nighttime arm/leg garments designed for sleep use

Compression bandaging systems and supplies

• For intensive phase of CDT
• Short-stretch bandages, padding, foam, gauze
• Per-application supply quantity allowances
• Higher quantity for intensive phase, ongoing supply for maintenance phase

Gradient compression wraps with adjustable straps (Velcro-closure devices)

• Adjustable Velcro devices (e.g., FarrowWrap, JoVi/CircAid alternatives)
• Useful when standard garments are difficult to don/doff
• Patient-specific medical necessity documentation

Accessories

• Donning/doffing aids
• Fillers, foam pieces, padding
• Bandage retainers
• Skin care items where covered

Frequency limits and reasonable and useful lifetime standards

CMS specified frequency and replacement standards per item category. Standard daytime garments typically have a useful lifetime of approximately 6 months for daily-use items. Beneficiaries with bilateral involvement, multiple affected body parts, or rapidly progressive disease may qualify for additional items based on medical necessity documentation.

HCPCS codes

CMS established HCPCS Level II codes specifically for LTA-covered items, published in transmittals and the HCPCS code set. Suppliers bill using these codes; the DME MAC processes claims accordingly.

Standard Written Order (SWO) requirements

Required elements

1. Beneficiary name
2. Order date
3. Description of the item (general descriptive name)
4. Quantity (if applicable)
5. Treating practitioner's name and NPI
6. Treating practitioner's signature

Who can write the SWO

• Physician
• Nurse practitioner
• Physician assistant
• Clinical nurse specialist

When SWO required

• Before delivery for most items
• Certain items may have face-to-face encounter requirements

Documentation supporting medical necessity

Beyond the SWO:

1. Lymphedema diagnosis documented in the medical record (ICD-10-CM codes: I89.0 lymphedema NEC; I97.2 postmastectomy lymphedema syndrome; Q82.0 hereditary lymphedema; etc.)
2. Clinical evaluation establishing affected body part(s), severity, functional impact
3. Plan of care for ongoing lymphedema management
4. Clinical justification for item type (standard vs custom, daytime/nighttime, adjustable wrap, bandaging system)
5. Treating practitioner involvement confirming medical necessity

A certified lymphedema therapist's evaluation and recommendation can support the SWO documentation but does not replace the SWO requirement (which must come from a qualifying practitioner).

Beneficiary cost-sharing

• Part B deductible: applies before Medicare pays
• 20% coinsurance: of Medicare-allowed amount after deductible
• Medigap (Medicare Supplement) may cover the coinsurance
• Medicaid for dual eligibles may cover cost-sharing
• Medicare Savings Programs (QMB, SLMB, QI, QDWI) may cover Part B premium and certain cost-sharing
• Medicare Advantage plans may have different cost-sharing structures but must cover the benefit

DME MAC jurisdiction — CGS Administrators (Jurisdiction C)

Georgia DMEPOS claims, including LTA-covered compression items, are processed by CGS Administrators as the DME MAC for Jurisdiction C, which covers Alabama, Arkansas, Colorado, Florida, Georgia, Louisiana, Mississippi, New Mexico, North Carolina, Oklahoma, Puerto Rico, South Carolina, Tennessee, Texas, U.S. Virgin Islands, Virginia, and West Virginia.

(Note: Palmetto GBA serves as the Part A/B MAC for Jurisdiction J including Georgia, processing outpatient therapy claims. DME MAC jurisdictions are organized separately from Part A/B MAC jurisdictions.)

CGS Administrators:

• Processes LTA compression item claims
• Issues redeterminations on appeal
• Applies CMS coverage and documentation guidance
• Provides supplier education
• Maintains relevant LCDs/articles

Contact: CGS Administrators DME MAC (general 1-866-238-9650 / supplier 1-866-270-4909, depending on contact type and updated CGS publication).

Coordination with outpatient therapy CDT

CDT — Complete Decongestive Therapy — is the gold-standard manual treatment for lymphedema:

Phases

1. Intensive phase (typically 2-6 weeks): manual lymphatic drainage, multilayered compression bandaging, exercise, skin care
2. Maintenance phase (lifelong): self-care including compression garments, self-MLD, exercise, skin care, periodic CLT follow-up

Coverage

• Outpatient PT/OT with CLT-certified therapist delivers the manual treatment under Part B outpatient therapy benefit
• Subject to post-BBA 2018 KX modifier threshold framework (CY 2026 $2,330 PT/SLP combined / $2,330 OT thresholds)
• LTA covers the compression items used during and after intensive phase

CLT certification

• Certified Lymphedema Therapist credential through LANA (Lymphology Association of North America) or other CLT-conferring programs
• Typically requires 135+ hours of specialized training

Major Georgia lymphedema care providers

Hospital-based cancer programs with lymphedema services

• Emory Healthcare — Winship Cancer Institute lymphedema program; outpatient PT/OT with CLT therapists
• Wellstar Health System — multi-site oncology rehabilitation including lymphedema
• Piedmont Healthcare — Piedmont Cancer Institute lymphedema services
• Northside Hospital — Northside Cancer Institute (one of largest community cancer programs in the U.S.) — extensive lymphedema services
• Augusta University Medical Center — Georgia Cancer Center
• Memorial Health Savannah — coastal Georgia
• Phoebe Putney South Georgia Medical Center — southwest Georgia
• Atrium Health Navicent — Macon and central Georgia
• Northeast Georgia Health System — Gainesville and northeast Georgia
• Children's Healthcare of Atlanta — pediatric lymphedema (for Medicare-eligible pediatric beneficiaries with ESRD or disability)

Independent outpatient therapy

• BenchMark Physical Therapy
• Drayer Physical Therapy
• Athletico Physical Therapy
• Smaller specialized lymphedema clinics

DMEPOS suppliers

• Major national DMEPOS suppliers (Edgepark, Byram, etc.)
• Specialty lymphedema product suppliers (with broad geographic reach for Medicare beneficiaries)
• Local Georgia DMEPOS suppliers
• Direct manufacturer programs (Juzo, Mediven/Medi, Sigvaris, Jobst, Solaris, etc.)

Worked examples

Example 1 — Fulton 70 breast cancer secondary lymphedema

Patient: 70-year-old Fulton County resident, 18 months post right total mastectomy with axillary lymph node dissection and adjuvant radiation; mild to moderate right upper extremity lymphedema diagnosed during follow-up at Emory. Pre-LTA reality: Beneficiary paid out of pocket for daytime garments (~$200/garment × 3 garments × 2 replacement cycles/year = ~$1,200/year minimum). Post-LTA coverage: Treating oncologist completes SWO; CLT at Emory evaluates and recommends 3 daytime garments + 1 nighttime garment + initial bandaging supply during 4-week intensive phase. Edgepark (DMEPOS supplier) bills CGS Administrators using LTA HCPCS codes. Medicare pays 80% of allowed amount after Part B deductible; Medigap covers 20% coinsurance. Outcome: Annual compression garment cost drops from $1,200+ to minimal cost (premiums + deductible).

Example 2 — DeKalb 75 gynecologic cancer survivor

Patient: 75-year-old DeKalb County resident, 3 years post hysterectomy with pelvic lymph node dissection and adjuvant radiation for endometrial cancer; bilateral lower extremity lymphedema. Care plan: Wellstar gyn-onc follow-up; CLT-led outpatient PT for intensive CDT (4 weeks) + LTA compression coverage for bilateral leg garments daytime + nighttime + ongoing maintenance supplies. Documentation: Lymphedema diagnosis (I97.2), bilateral involvement clinical findings, CLT evaluation, SWO from Wellstar gyn-onc. Coverage: LTA covers compression items; Part B outpatient therapy covers CDT under KX framework as intensive phase expenditures approach annual threshold.

Example 3 — Cobb 68 prostate cancer-related LE lymphedema

Patient: 68-year-old Cobb County resident, post prostatectomy with pelvic radiation, lower extremity lymphedema worse on left. Setting: Piedmont Cancer Institute; CLT outpatient at Piedmont rehab. Care plan: Intensive CDT (3 weeks) with bandaging supplies; maintenance with daytime knee-high and thigh-high garments + nighttime garment + adjustable Velcro wrap for night-time alternative when garment is difficult to don. LTA application: Multi-item coverage including standard garments + adjustable wrap + bandaging supplies during intensive phase.

Example 4 — Worth County 72 primary lymphedema (rural access)

Patient: 72-year-old Worth County (rural southwest Georgia) resident with lifelong primary lymphedema (Meige disease). Setting: Phoebe Putney Cancer Center / outpatient rehab — limited rural CLT availability but accessible. Care plan: CLT follow-up annually; LTA-covered compression garments for bilateral leg maintenance. Access considerations: Mail-order DMEPOS supplier for compression items; local PCP completes SWO; coordination with Phoebe Putney CLT for clinical evaluation. Outcome: Rural beneficiary access to compression coverage that was previously inaccessible.

Example 5 — Bibb 80 head/neck cancer lymphedema

Patient: 80-year-old Bibb County resident, 2 years post oropharyngeal cancer treatment with neck dissection and radiation; cervical and submandibular lymphedema. Setting: Atrium Health Navicent oncology and CLT outpatient. Care plan: Specialized head/neck CLT outpatient + LTA-covered cervical compression garments and night-time options. LTA application: Custom-fit considerations for head/neck garments; specialized CLT documentation; SWO from treating ENT-oncologist.

Example 6 — Hall 67 LTA claim denial appeal

Patient: 67-year-old Hall County resident, lymphedema from melanoma sentinel node procedure; LTA compression garment claim denied citing documentation insufficiency. Appeal:

1. Redetermination to CGS Administrators with supplemented documentation — lymphedema diagnosis ICD-10, CLT evaluation, complete SWO, treating provider clinical note
2. QIC reconsideration if redetermination upheld denial
3. ALJ hearing if needed Outcome: Comprehensive documentation typically resolves denial at redetermination.

Best practices for Georgia providers

1. Educate Georgia oncologists, gyn-oncs, urologists, surgeons, and PCPs about LTA coverage so SWOs are issued promptly post-diagnosis
2. Build referral workflows to CLT-certified outpatient therapists and DMEPOS suppliers
3. Document lymphedema diagnosis with appropriate ICD-10-CM codes
4. Complete SWOs comprehensively with all required elements
5. Coordinate CLT clinical evaluations to support medical necessity
6. Use specific HCPCS codes correctly per CMS guidance
7. Educate beneficiaries on the new benefit and frequency limits
8. Coordinate with DMEPOS suppliers for accurate billing
9. Track replacement schedules to support frequency-justified claims
10. Issue ABN appropriately when a specific item is expected to be denied
11. Maintain LCD/article compliance per CGS Administrators publications
12. Coordinate compression item use with intensive CDT outpatient therapy
13. Document custom-fit medical necessity when standard garments are inadequate
14. Reference Lymphedema Treatment Act resources (LE&RN, NLN, Lymphedema Advocacy Group) for current updates

Common compliance issues

1. SWO incomplete or missing — leading cause of denial
2. Lymphedema diagnosis not documented in the medical record
3. HCPCS code errors — wrong code for specific item
4. Frequency over limit — exceeded annual or per-body-part quantity without medical necessity justification
5. Custom-fit billed without justification when standard would have been adequate
6. Inadequate clinical evaluation documentation
7. Confusion between LTA-covered items and traditional DMEPOS — different code sets, frequency rules
8. Confusion about which MAC processes claims — CGS Administrators DME MAC for compression items; Palmetto GBA Part A/B MAC for outpatient therapy
9. Failing to issue ABN when a specific item is expected to be denied
10. Coordination gaps between CLT, oncologist, PCP, and DMEPOS supplier
11. Replacement timing errors — supplier delivers before reasonable and useful lifetime elapsed
12. MA plan procedural confusion — plan-specific prior authorization requirements
13. Out-of-state CLT or supplier complications for Georgia beneficiaries
14. Beneficiary self-purchase confusion — coverage available but not utilized due to lack of awareness

Frequently asked questions

1. What is the Lymphedema Treatment Act? A federal law enacted as Section 4133 of the Consolidated Appropriations Act, 2023 (Public Law 117-328), creating a new Medicare Part B benefit category for lymphedema compression treatment items.

2. When did the LTA take effect? January 1, 2024.

3. When was the law signed? December 29, 2022 by President Biden.

4. What statutory sections did it add? Section 1861(s)(2)(JJ) and Section 1861(iii) of the Social Security Act.

5. What items are covered? Daytime compression garments (standard and custom), nighttime garments, compression bandaging systems and supplies, gradient compression wraps with adjustable straps, and accessories.

6. What about CDT outpatient therapy? CDT outpatient therapy was already covered under Part B and remains covered (subject to post-BBA 2018 KX modifier threshold framework). LTA adds the compression item coverage.

7. Do I need a prescription? Yes — a Standard Written Order (SWO) from your physician, NP, PA, or CNS.

8. What is my cost? Part B deductible plus 20% coinsurance of Medicare-allowed amount. Medigap or other supplemental coverage may cover the coinsurance.

9. Who is the DME MAC for Georgia? CGS Administrators is the DME MAC for Jurisdiction C, which includes Georgia.

10. Where do I get the compression items? Through Medicare-enrolled DMEPOS suppliers, including specialty lymphedema product suppliers and national DMEPOS suppliers.

11. How many garments will Medicare cover per year? CMS established frequency limits per item category — generally multiple daytime garments and at least one nighttime garment per affected body part per year, with bandaging supplies more frequent during intensive treatment.

12. Are custom-fit garments covered? Yes, when medical necessity documentation supports custom-fit over standard.

13. What about adjustable Velcro wraps? Covered when medically appropriate.

14. Does Medicare Advantage cover LTA items? Yes — MA plans must cover the benefit at least equivalent to Original Medicare; plan-specific procedural requirements (prior authorization, in-network suppliers) may apply.

15. What if my claim is denied? Standard appeals process: redetermination (120 days), QIC reconsideration (180 days), ALJ hearing (60 days), Medicare Appeals Council (60 days), federal court (60 days).

16. Who advocated for the LTA? The Lymphedema Advocacy Group led the multi-year campaign with broad cancer survivor, professional, and bipartisan congressional support.

17. Are pediatric beneficiaries covered? Medicare-eligible beneficiaries (typically 65+, or under 65 with disability or ESRD) are covered. The LTA benefit applies regardless of age within the Medicare-eligible population.

18. What about lymphedema from filariasis? Lymphedema from any qualifying etiology is covered when the diagnosis is established and items are medically necessary.

19. What about people who already paid out of pocket pre-2024? The LTA is prospective. Out-of-pocket purchases before January 1, 2024 are not retroactively reimbursed by Medicare.

20. Where can I find Georgia CLT therapists? Major Georgia cancer center programs, hospital outpatient rehabilitation departments, and specialty CLT clinics. The Lymphology Association of North America (LANA) maintains a directory.

21. How does this work with the BBA 2018 therapy cap repeal? The therapy cap repeal applies to outpatient therapy services. The LTA applies to compression items. They work alongside each other — both are needed for comprehensive lymphedema care.

22. What about home health therapy for lymphedema? Home health therapy under the home health benefit is separate from outpatient therapy under Part B. Beneficiaries who are homebound and meet home health eligibility may receive CDT in the home; LTA-covered compression items remain available regardless.

23. Can I use a non-enrolled supplier? For coverage under Medicare, the supplier must be Medicare-enrolled. Non-enrolled suppliers' sales would not be reimbursable.

24. How do I find an enrolled supplier in Georgia? Medicare.gov supplier directory, or referral from your CLT therapist or cancer center social worker.

25. Where can I get help with LTA coverage in Georgia? GeorgiaCares SHIP (1-866-552-4464), Medicare Rights Center (1-800-333-4114), Center for Medicare Advocacy, LE&RN, Lymphedema Advocacy Group, your cancer center social worker.

Get help with lymphedema care and LTA coverage in Georgia

• Medicare — 1-800-MEDICARE (1-800-633-4227); medicare.gov
• CGS Administrators (DME MAC Jurisdiction C) — cgsmedicare.com (DME)
• Palmetto GBA (Part A/B MAC for GA — outpatient therapy) — 1-866-238-9650; palmettogba.com
• GeorgiaCares SHIP — 1-866-552-4464; georgiacares.org
• Medicare Rights Center — 1-800-333-4114; medicarerights.org
• Center for Medicare Advocacy — medicareadvocacy.org
• Acentra Health Georgia QIO — 1-844-455-8708
• Atlanta Legal Aid — 404-377-0701; atlantalegalaid.org
• Georgia Legal Services Program — 1-800-498-9469; glsp.org
• Lymphedema Advocacy Group — lymphedematreatmentact.org (LTA campaign)
• Lymphatic Education & Research Network (LE&RN) — lymphaticnetwork.org
• National Lymphedema Network (NLN) — lymphnet.org
• Lymphology Association of North America (LANA) — clt-lana.org (CLT directory)
• APTA Georgia — gaapta.org
• AOTA — aota.org
• ASHA — asha.org
• 211 Georgia — dial 211
• Eldercare Locator — 1-800-677-1116; eldercare.acl.gov
• Georgia Department of Public Health — 404-657-2700; dph.georgia.gov
• Social Security Administration — 1-800-772-1213; ssa.gov

This guide is provided for educational purposes by Brevy. It does not constitute legal or medical advice. Coverage determinations depend on individual circumstances, documentation, and DME MAC application. HCPCS codes, frequency limits, and reasonable and useful lifetime standards are established by CMS and may be updated. Consult Medicare, CGS Administrators, GeorgiaCares SHIP, your treating provider, certified lymphedema therapist, or qualified legal counsel for case-specific guidance. Last verified: 2026-05-14.